Home   Business   Article

Expedeon becomes a preferred supplier for Babraham-based Cell Guidance Systems


By Paul Brackley


Dr Heikki Lanckriet, CEO and CSO of Expedeon. (6447076)
Dr Heikki Lanckriet, CEO and CSO of Expedeon. (6447076)

Over-based Expedeon AG has signed a supply and licence agreement with Cell Guidance Systems on Babraham Research Campus.

It will use Expedeon’s proprietary Lightning-Link Rapid Biotin technology for the development and production of its TRIFic immunoassays.

Lightning-Link technology is used for the direct labelling of antibodies or proteins for use in R&D applications, drug discovery and the development of diagnostic kits.

It enables the direct conjugation of biomolecules to either Biotin or Streptavidin with only 30 seconds hands on time and with 100 per cent recovery of materials.

Cell Guidance Systems, established in 2010, develops therapeutic products along with medical research tools and technologies.

It has been using Expedeon’s Lightning-Link technology for more than two years. Under the terms of the new deal, Expedeon becomes its preferred immunoreagent supplier.

Expedeon kit. (6447079)
Expedeon kit. (6447079)

Dr Heikki Lanckriet, CEO and CSO of Expedeon, said: “We have been working with Cell Guidance Systems for several years and are delighted to strengthen the relationship.

“ Our technology provides a rapid, easy to use, efficient method of labelling antibodies and we are confident it will serve Cell Guidance Systems very well in the development and production of their TRIFic detection assay kits.

“This latest agreement follows a number of licence and supply agreements with various partners for Lightning-Link, underlining the increasing demand in academia and industry for our proprietary solutions, which help drive the life sciences research sector.”

Dr Laur-Alexandru Botos, senior research scientist at Cell Guidance Systems said: “TRIFic™ kit is an exquisitely sensitive europium time resolved immunofluorescence assay for exosome markers. The Lightning-Link Rapid Biotin technology is used to generate stable biotin conjugates as components of this platform.

“We have found Expedeon’s cutting-edge technologies to be reliable and meet the high standards that our customers demand, and will be invaluable in ensuring the TRIFic detection assay kits enable researcher to save time and costs.”



COMMENTS
()


Iliffe Media does not moderate comments. Please click here for our house rules.

People who post abusive comments about other users or those featured in articles will be banned.

Thank you. Your comment has been received and will appear on the site shortly.

 

Terms of Comments

We do not actively moderate, monitor or edit contributions to the reader comments but we may intervene and take such action as we think necessary, please click here for our house rules.

If you have any concerns over the contents on our site, please either register those concerns using the report abuse button, contact us here.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies - Learn More